One such mechanism involves a reduction in putrescine synthesis due to GSDMD deficiency in VSMCs, resulting in an anti‐inflammatory phenotype and decreased susceptibility to AAA formation in mice. The gene discussed is GSDMD; the disease is triple-A syndrome.